Contact Information
Company Information
Company
MannKind Corporation
Annual Revenue
29274000.0
Technologies
Salesforce
WorldwideDNS
Outlook
Marketo
Adobe Marketing Cloud
Hubspot
Remote
Keywords
healthcare
biotechnology
life sciences
biotechnology: pharmaceutical preparations
health care
pharmaceutical manufacturing
inhaled insulin
afrezza
endocrine therapies
orphan lung diseases
diabetes management
device technology
technosphere technology
clinical trials
pulmonary arterial hypertension
dry powder inhalation
nontuberculous mycobacterial disease
tyvaso dpi
insulin delivery patch
v-go
biopharmaceuticals
fda approval
clinical efficacy
medical devices
drug delivery systems
patient-centric solutions
clinical safety
diabetes technology
pharmaceutical collaboration
ventilator technology
insulin absorption
healthcare innovation
chronic lung disease
respiratory therapy
chronic obstructive pulmonary disease
biomedical research
formulation development
diabetes education
medical product development
types 1 & 2 diabetes
pulmonary diseases
metabolic conditions
retro-inhalation
biosimilar medications
medical grants
drug-device combinations
metabolic disorders
exercise interventions
clinical pharmacology
patient adherence
subcutaneous insulin
chronic care management
therapeutic innovations
personal health management
patient-engagement strategies
biopharmaceutical
innovative therapies
endocrine diseases
rapid-action insulin
nontuberculous mycobacterial lung disease
pediatric insulin therapy
wearable insulin delivery
clinical development
patient-centric approach
healthcare providers
specialty pharmacies
pharmaceutical industry
chronic health conditions
digital health platform
drug formulation
patient outcomes
healthcare accessibility
financial growth
regulatory submissions
market expansion
therapeutic innovation
health
wellness & fitness
hospital & health care
pharmaceuticals
medical
Get Full Contact Details
Subscribe to reveal email addresses and export contacts.
View Plans